Delivering new experimental medicines and developing enhanced clinical trial capacity in adult and paediatric neuromuscular diseases.
From Centre Director
The MDUK Oxford Neuromuscular Centre represents a very exciting, new opportunity to transform the treatment landscape for neuromuscular diseases. Our aim is to lead innovation throughout the translational pathway from new treatments to innovative new ways of evaluating these in patients with the goal of bringing innovative new treatments to benefit neuromuscular disease patients as quickly as possible.
Please join our efforts!
Professor Matthew Wood